or reduce the effects of IVH. Methods to grade IVH severity, however, are not well established.
The IVH, 11 Graeb, 10 and LeRoux scores 17 were developed to estimate IVH severity based on gross hemorrhage size and the presence of dilation within each ventricle (Fig.  1) . The scores are useful for IVH evaluation at admission and have been used to define IVH severity 20 or to select patients for studies; 21 however, their clinical effectiveness to assess IVH or to predict outcome after ICH remains unclear. The aim of this study was to prospectively evaluate the predictive accuracies of the IVH, Graeb, and LeRoux scores for functional outcome at discharge in a singlecenter, consecutive series of ICH patients with IVH. We also sought to investigate the subacute IVH dynamic, as well as the impact of EVD placement on IVH severity and outcome.
Methods

Patient Selection and Data Collection
All patients with spontaneous ICH admitted to the neurological intensive care unit of Columbia University Medical Center between February 2009 and February 2011 were offered participation in the Columbia University Intracerebral Hemorrhage Outcomes Project. The study was approved by the hospital's institutional review board, and in all cases, informed consent was obtained from the patient or surrogate. The diagnosis of ICH was established by CT scan. Patients were included in the analysis if they had spontaneous nontraumatic ICH with evidence of IVH on CT scans upon admission and within 24 hours of onset. 11 Patients were excluded if the ICH was due to secondary causes such as trauma, aneurysm, or arteriovenous malformation rupture, or hemorrhagic conversion of an infarct.
Clinical Assessment and Management
All patients received standard neurological intensive care unit management according to our institutional protocol, corresponding to the latest American Heart Association guidelines. 2, 19 An EVD was placed in patients with evidence of symptomatic hydrocephalus and a GCS score < 8. The catheters were left in place until the total daily amount of drained CSF became less than 100 ml and no ventriculomegaly or increased intracranial pressure was recorded after 48 hours of clamping. Surgical hematoma evacuation was strongly considered for patients with cerebellar hemorrhage with clinical deterioration or those with brainstem compression and/or hydrocephalus. Surgery was also considered for patients with lobar clots greater than 30 ml and within 1 cm of the cortical surface. The decision to administer intrathecal tPA was based on the preference of the treating neurosurgeon. The protocol consisted of removal of approximately 3 ml of CSF followed by 1 mg of tPA delivered in 1 ml of saline, and a 2-ml saline flush. Patients received intrathecal tPA twice daily until the decision was made to discontinue the therapy, based on nearly complete clearance of blood from the ventricles. Further details regarding the clinical management of the patients have been described separately. 7 Baseline demographics, medical history, clinical presentation, and clinical course, including EVD insertions, were prospectively recorded.
Radiological Assessment
All CT scans were assessed using identical techniques. Two authors (G.A. and C.P.K.) analyzed the scans while blinded to radiologists' reports and patient outcomes. Consensus was then reached for each scan. Admission CT scans performed within 24 hours of onset were reviewed for ICH location, ICH volume, and presence of intraventricular extension. Intraventricular hemorrhage severity was assessed by determining the IVH, 11 Graeb, 10 and LeRoux scores 17 according to previously published criteria. Intracerebral hemorrhage volume was determined using the ABC/2 method. 16 Intraventricular hemorrhage volume was measured as previously described, using a computerbased planimetric analysis program, Medical Image Processing, Analysis and Visualization (NIH).
11 Scans were evaluated for the presence of hydrocephalus and the official radiology reports were consulted in questionable cases. Intraventricular hemorrhage was scored and ICH and IVH volumes were assessed based on the last scan performed during this period. 
Outcome Assessment
Survival and functional outcomes at discharge were assessed using the mRS, and patients were routinely followed up after discharge by the study neurosurgeon (E.S.C.). Poor outcome was defined as mRS scores ≥ 3.
Statistical Analysis
Continuous variables were dichotomized based on clinical cutoff points or median values if they were not normally distributed. The chi-square or Fisher exact tests were used to find significant associations between categorical or dichotomized variables. The 2-sided Student t-test or the Mann-Whitney U-test was used for normally and nonnormally distributed continuous variables, respectively. Receiver operating characteristic analysis was used to determine the predictive accuracies of the LeRoux, Graeb, and IVH scores with regard to discharge poor outcome, as measured by the AUROC. The ROC analysis measures the ability of a scale to discriminate patients with a higher probability of poor outcome from those with a lower probability of poor outcome by assigning the former a higher score, and has been used to determine a clinical grading scale's predictive accuracy for outcome. 4, 5, 9 An AUROC greater than 0.7 is generally considered useful, and an AUROC between 0.8 and 0.9 indicates excellent accuracy.
8 Dependent AUROCs were compared nonparametrically, 13 and the maximum Youden Index was identified for each scale to assess their prognostic performance. The maximum Youden Index is the optimization of a function that gives equal weight to sensitivity and specificity. It is a method of ROC analysis that offers an alternative measure to AUROC; whereas AUROC concerns a variable's discriminative utility at all cutoff points, the maximum Youden Index concerns only the cutoff point at which the combination of sensitivity and specificity is maximal. A probability value ≤ 0.05 was considered statistically significant. Data analysis was performed with SPSS version 17.
Results
Baseline Characteristics
Of the 142 primary ICH patients enrolled during the study period, 73 (51.4%) met the inclusion criteria and were included in the analysis. Baseline demographic and admission characteristics are outlined in Table 1 . Patient characteristics were similar to previously reported larger cohorts with ICH. 14, 15, 29, 31, 32 The mean age of the entire cohort was 62.6 years, 47% were women, and 80% had a history of hypertension. Fifty percent of patients had GCS scores < 8 at admission. Overall, 8% of patients received intrathecal tPA, and 53% and 15% underwent EVD placement and hematoma evacuation, respectively. Table 1 lists radiographic characteristics of the study cohort. Mean ICH and IVH volumes were 27 ± 33 ml and 17 ± 22 ml, respectively. Sixty-seven percent had radiographic evidence of hydrocephalus at admission. Median IVH, Graeb, and LeRoux scores were 13, 8, and 6, respectively. Within 6 days, the incidence of hydrocephalus decreased to 28% (p = 0.016). Median IVH, Graeb, and LeRoux scores significantly decreased to 9 (p = 0.005), 4 (p = 0.002), and 4 (p = 0.003), respectively. Thirty-four patients (46.5%) had an increase in their IVH severity according to IVH, Graeb, and LeRoux scores.
Radiographic Characteristics
Clinical Outcome and Change in IVH Severity
Twenty-five patients (34%) died during initial admission. Poor outcome (mRS score ≥ 3) was noted in 55 patients (75%). Increase or decrease in IVH severity within 6 postbleed days was not associated with outcome (p = 0.762 and p = 0.513, respectively). Fig. 2  right) . Furthermore, the 3 scores had similar maximum Youden Indices and associated sensitivities and specificities when assessed at admission and within 6 days postictus (Table 2) . Admission IVH score of 9 (IVH volume of approximately 6.0 ml) and 7 (IVH volume of approximately 3.3 ml) were associated with maximum Youden Index, and thus were identified as an optimal cutoff point for poor outcome.
Comparison of IVH Grading Scales in Predicting Outcome
Impact of EVD on IVH Severity and Outcome
At admission, patients who received an EVD had similar demographic characteristics as compared with those who did not (Table 3) . The proportion of patients with a GCS score < 8 was significantly higher in the EVD group (p = 0.015). The EVD group also had significantly worse radiographic findings with higher mean IVH volumes compared with the non-EVD group (23 ± 26 ml vs 9 ± 11 ml, respectively; p = 0.003) and increased incidence of hydrocephalus (82% vs 50%, respectively; p = 0.004). Intraventricular hemorrhage severity, as assessed by IVH (17 vs 8, respectively; p < 0.001), Graeb (11 vs 3, respectively; p < 0.001) and LeRoux scores (7 vs 3, respectively; p < 0.001) were significantly worse in the EVD group as compared with the non-EVD group (Table 3) . Within 6 days of admission, the median IVH (17 vs 10; p = 0.001), Graeb (7 vs 5; p < 0.001) and LeRoux scores (11 vs 5, p < 0.001) significantly decreased in the EVD group compared with the admission scores. During the same period, there was no significant change in median IVH (8 vs 9, p = 0.058), Graeb (3 vs 4, p = 0.182) or LeRoux scores (3 vs 4, p = 0.091) among patients who did not undergo EVD placement. The EVD and non-EVD groups had similar postadmission IVH, Graeb, and LeRoux scores (Table 3 ). In addition, there was no significant difference in the incidence of poor outcome between the EVD and non-EVD groups (79.5% vs 70.6%, p = 0.251).
Discussion
Comparison of the IVH, Graeb, and LeRoux Scores
In this study, we have demonstrated that the admission IVH, Graeb, and LeRoux scores predict functional outcome at discharge with good accuracy. The 3 scores retained their predictive accuracy when assessed within 6 days postictus, suggesting that they are robust against potentially confounding factors, such as discrepancies in medical or surgical management among patients. Although the scores were not intended for predicting outcome per se, their predictive accuracies reflect their ability to assess IVH severity and risk-stratify patients with regard to outcome. Therefore, any 1 of the 3 scores can be considered for IVH evaluation in the setting of ICH and assessment of hemorrhage progression and treatment response, as well as for incorporation into ICH grading scales for improved outcome prediction and risk-stratification.
To our knowledge, this is the first study to directly compare the 3 most commonly used IVH grading scales for their abilities to predict outcome after ICH with intraventricular extension. With rapidly growing interest in novel therapies for IVH in the setting of ICH, simple and accurate assessment of IVH is becoming critical for systematic evaluation and monitoring of disease progression and clinical efficacy of treatments. However, there is currently no widely accepted, standardized method for measuring IVH severity or volume. The recently developed IVH score is different from the Graeb and LeRoux scores in several aspects. First, unlike the Graeb and LeRoux scores, the IVH score was specifically developed in a cohort of ICH patients with IVH, and hence, may better account for the characteristics of IVH in this specific population. Furthermore, the IVH score may be more sensitive to the differences in severity as it assesses hemorrhage size in thirds rather than halves. The score also considers hydrocephalus, an independent predictor of outcome after ICH, 6 separately from IVH volume in each ventricle. This may enable the IVH score to evaluate the severity of IVH with better accuracy as compared with the other scales because hemorrhage burden and ventricular expansion do not necessarily always go hand-in-hand. Nevertheless, in our cohort, the difference in how hydrocephalus is evaluated by each scale did not translate into improved predictive accuracy for the IVH score. Also in our cohort, the potential advantages of the IVH score failed to translate into improved predictive accuracy for outcome. Given the comparable performances of the 3 scores, one important feature that distinguishes the IVH score from the others is its ability to rapidly estimate IVH volume without the need for time-consuming calculations that often involve computer-assisted planimetric analysis. This is important because, once validated as a reliable and accurate volume estimation tool, the IVH score will allow quick and routine clinical assessment of IVH and total volume (IVH and ICH volume) at admission and during treatment course. This will be useful to researchers as clinical trials move toward novel therapies that address both ICH and IVH volumes in recognition of their independent effects on outcome.
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Effects of Alterations in IVH Severity and Volume on Outcome
Intraventricular hemorrhage volume is directly related to the risk of poor outcome after ICH, with volumes of > 20 ml often leading to death. 24, 25, 30 In our cohort, admission IVH volume of 6.0 ml was associated with a significant increase in the likelihood of poor functional outcome. This suggests that even relatively small IVH can lead to clinically significant ventricular dysfunction, intracranial hypertension, reduced cerebral perfusion, and secondary cerebral injuries. 11 The lower threshold for poor outcome at postadmission may be due to the prolonged exposure of the ventricles to blood, which worsens IVH-mediated injuries and neurological outcome.
22,23
Intraventricular hemorrhage is a dynamic condition and its course depends on many factors, including mean arterial pressure, baseline ICH volume, and treatment.
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Nearly half of our cohort experienced an increase in their IVH severity, suggesting that IVH progression is common beyond the first 24 hours despite standard neurocritical management. Although hydrocephalus resolved and IVH grades improved in a significant number of patients, the overall mean IVH volume did not significantly change. Furthermore, increase or decrease in IVH severity within 6 days of hemorrhage was not significantly associated with outcome. This suggests that subacute worsening in IVH volume may not significantly worsen outcome once patients are medically stabilized and hydrocephalus and intracranial pressure are optimally managed. Surprisingly, a decrease in IVH severity also did not have significant influence on outcome. It is possible that IVH either causes a considerable amount of its damage in the early periods, or IVH severity within the first 24 hours determines the extent of cerebral injuries to come. Studies have reported that early changes in IVH severity may significantly influence outcome. Steiner et al. 25 have reported that 17% of ICH patients had IVH expansion within 24 hours of symptom onset and that the growth was associated with severe disability and death. We did not investigate the incidence or degree of IVH growth in the first 24 hours. Further studies are needed to determine the IVH dynamics and its clinical impact on hospital course and outcome. Continued investigation into the IVH pathophysiology may also help identify an optimal timing and degree of intervention.
Impact of an EVD on Outcome in ICH Patients With IVH
Current treatment for IVH in ICH patients is EVD-assisted drainage but its usefulness remains controversial.
21
In our cohort, patients who underwent EVD placement had significantly higher IVH volume and incidence of hydrocephalus at admission with significantly worse IVH, as assessed by the IVH grading scales. Based on our management protocol, it is likely that a majority of patients with hydrocephalus in the EVD group were symptomatic from ventricular expansion. Interestingly, patients who underwent EVD placement and those who did not had similar IVH severity within 6 days of hemorrhage, suggesting that an EVD was effective at alleviating IVH and ventricular obstruction. Although EVD insertion was not associated with outcome, it is important to recognize that the EVD group had similar mortality rates and functional outcome as those who did not receive an EVD, despite having a significantly worse prognosis at admission, which is consistent with previous reports. 6, 30 Although this prospective observational study was not designed to isolate the impact of EVD on outcome, our results suggest EVD placement, in conjunction with neurocritical care and appropriate surgical and medical interventions, may be beneficial in a subset of ICH patients with IVH with particularly dismal prognosis based on admission characteristics. A randomized clinical trial is needed to determine whether EVD insertion improves outcome in ICH patients with IVH.
Study Limitations
This study has several limitations. First, only the admission scans and the last scan performed within 6 days were used for our study. All the patients received at least 1 scan during this time period but they were not performed on the same postbleed day. It is possible that not all worsening or improvement in IVH was included in our analysis.
Second, we estimated the IVH volume based on the IVH score. Although this method has been shown to be accurate, 11 it is novel and is yet to be conclusively validated. In addition, this study may have been underpowered for differentiating the predictive accuracies of the scales, as well as detecting small difference among subgroups of patients. Our results must be validated in future studies with larger cohorts and longer follow-up periods that are sufficiently powered to control for the heterogeneity of the study population and treatments.
Conclusions
The IVH score, Graeb score, and LeRoux score assessed at admission predict discharge functional outcome in ICH patients with IVH with good accuracy. Therefore, any 1 of the 3 scores may be considered for IVH assessment in the setting of ICH or for improving the performance of ICH grading scales that incorporates IVH severity for outcome prediction. Although IVH progression is common after the first 24 hours even with standard optimal neurocritical care, its impact on clinical outcome needs to be further elucidated. Future research is also needed to better understand IVH pathophysiology, which may help define optimal timing and degree of intervention. Although EVD placement remains one of the main treatments of IVH and acute hydrocephalus, its impact 
